Advisory committees might live to regret their increasing role as policy advisors

The logical extension of the committee's claim is that the government should not fund anything today on the basis of a hypothetical risk of higher prices for superior therapies in the future. Besides being asinine, it also belies the reality of a committee and policy framework that is remarkably effective at lowering prices.  …